Hologic Company

Hologic engages in the development and supply of medical imaging systems and diagnostic products focused on the healthcare needs of women. The company operates in five segments: breast health (44% of sales), diagnostics (39%) surgical (14%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.
Technology: Biomarkers of Female Cancers
Industry: General Healthcare
Headquarters: Marlborough, Massachusetts, United States
Founded Date: 01-01-1985
Employees Number: 10001+
Funding Status: IPO
Acquisitions Number: 19
Investors Number: 1
Total Funding: $450,000,000
Estimated Revenue: $500M to $1B
Last Funding Date: 2010-11-30
Last Funding Type: Post-IPO Equity

Visit Website
info@hologic.com
http://twitter.com/hologic
Register and Claim Ownership